COCH — Envoy Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1840877 ·
Last close
$6.87
Market Cap
$53.20M
52W High
$9.54
52W Low
$3.63
ADV30
27,154
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 66,000 | -178,000 | -5,537,000 | -3,932,000 | 19,158,000 | 14,570,000 | 20,298,000 |
| Jun 2026 | 51,000 | -227,000 | -5,569,000 | -5,982,000 | 23,949,000 | 19,679,000 | 20,255,000 |
| Mar 2026 | 39,000 | -274,000 | -5,959,000 | -4,351,000 | 29,822,000 | 25,251,000 | 19,270,000 |
| Dec 2025 | 75,000 | -136,000 | -6,385,000 | -6,586,000 | 8,558,000 | 3,739,000 | 20,325,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,232,000
Investing CF
$-205,000
Financing CF
$33,454,000
CapEx
$-206,000
Dividends Paid
$1,000
Buybacks
—
EPS Diluted TTM
$-5.55
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-331,609,000
Inventory
$1,510,000
Receivables
$68,000
ST Investments
—
EBIT TTM
$-20,851,000
Pretax Income TTM
$-20,851,000
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$207,000
EBITDA
$-23,128,000
Free Cash Flow
$-8,223,750
Enterprise Value
$35,939,168
Total Cash
$19,679,000
Total Debt
$810,000
Shares Out
7,744,488
Trailing EPS
$-4.57
Book Value
$-4.07
ROE
—
ROA
-86.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 241,000 | -22,270,000 | -23,756,000 | 8,558,000 | 20,325,000 | -11,767,000 | -18,201,000 |
| Dec 2024 | 225,000 | -19,256,000 | -20,795,000 | 11,538,000 | 30,380,000 | -18,842,000 | -17,949,000 |
| Dec 2023 | 316,000 | -18,359,000 | -29,922,000 | 8,271,000 | 10,047,000 | -1,776,000 | -17,091,000 |
| Dec 2022 | 237,000 | -8,706,000 | -15,923,000 | 2,556,000 | 38,751,000 | -36,195,000 | -8,805,000 |
TTM Snapshot
Revenues TTM
$207,000
NetIncome TTM
$-23,401,000
OpCashFlow TTM
—
Assets (Latest)
$23,949,000
Forward EPS
$-2.23
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AURX | Nuo Therapeutics, Inc. | $52.79M | $1.09 | — |
| HYPR | Hyperfine, Inc. | $51.10M | $0.56 | — |
| POSC | POSITRON CORP | $55.84M | $1.70 | — |
| RNXT | RenovoRx, Inc. | $50.18M | $1.04 | — |
| CNXU | Conexeu Sciences Inc. | $56.41M | $2.00 | — |
News headlines (Yahoo Finance, 1h cache)
Envoy Medical Expands Intellectual Property Portfolio to 99 Patents with New U.S. and Hong Kong Patent Grants
2026-11-17 14:15 · Yahoo
Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-11-10 13:30 · Yahoo
Envoy Medical Inc (COCH) (Q3 2026) Earnings Call Highlights: Acclaim Trial Fully Enrolled as ...
2026-11-06 03:14 · Yahoo
Envoy Medical, Inc. Q3 2026 Earnings Call Summary
2026-11-05 21:58 · Yahoo
Envoy (COCH) Q3 2026 Earnings Call Transcript
2026-11-05 20:13 · Yahoo
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Tops Revenue Estimates
2026-11-05 13:35 · Yahoo
Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
2026-11-05 12:00 · Yahoo
Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th
2026-10-28 12:30 · Yahoo
Envoy Medical Announces Reverse Stock Split
2026-10-22 12:30 · Yahoo
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
2026-10-20 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.